Status:
COMPLETED
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study aims at evaluating, in a proof of concept approach, the outcome of patients presenting with acute ST-elevation myocardial infarction within 3 hours of symptom onset in either a pre-hospital...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age equal or greater than 18 years
- Onset of symptoms \< 3 hours prior to randomisation 3.12-lead ECG indicative of an acute STEMI
- Informed consent received
- Exclusion criteria:
- Medical history, procedures, medication administration or the presence of factors that would in general predispose to bleeding events and/or the inability to evaluate the study primary endpoint
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
1899 Patients enrolled
Trial Details
Trial ID
NCT00623623
Start Date
March 1 2008
End Date
September 1 2012
Last Update
August 1 2019
Active Locations (201)
Enter a location and click search to find clinical trials sorted by distance.
1
1123.28.43009 Boehringer Ingelheim Investigational Site
Salzburg, Austria
2
1123.28.43010 Boehringer Ingelheim Investigational Site
Salzburg, Austria
3
1123.28.43001 Boehringer Ingelheim Investigational Site
Vienna, Austria
4
1123.28.43002 Boehringer Ingelheim Investigational Site
Vienna, Austria